China’s Hua Medicine Licenses Worldwide Rights To Roche Diabetes Compound, More Deals On The Way
This article was originally published in The Pink Sheet Daily
Executive Summary
Chinese startup Hua Medicine kicks off its in-licensing strategy with an IND-ready glucokinase activator from Roche.